Why the study?
The role of adiponectin in neonatal metabolic disorders remains unclear, and whether gestational hypertension lowers cord blood adiponectin levels was unknown.
Does maternal gestational hypertension lower cord blood adiponectin levels in neonates compared to normotensive pregnancies?
Does maternal gestational hypertension lower cord blood adiponectin levels in neonates compared to normotensive pregnancies?
Gestational hypertension does not significantly alter cord blood adiponectin levels in neonates.
The abstract is truncated and the key finding is missing — I'll retrieve the paper so the implication can be written from the actual verdict.Found the paper; next I’ll pull the full text for the primary endpoint and verdict.Do not treat cord adiponectin as a marker of gestational hypertension exposure; leaves open other drivers of later metabolic risk.
No takes yet. Share an insight, caveat, or question.
Czubilińska-Łada et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: